Mission

“To develop evidence-based knowledge and technologies that will allow the identification of and the coordinated response to emerging infectious threats in a timely manner”

This mission we implement through the following strategies :

• Documenting the etiologies of pneumonia in children and adult, with special focus on preventable infections (through vaccine and antibiotics);

• Developing novel diagnostic tools that will strengthen both biological and epidemiological research methods for ARI;

• Improving the understanding of the pathogenesis of ARI and develop novel therapeutic options;

• Teaching and training of young medical doctors and researchers with a focus on public health and biomedical science.

The specific goals of RESPARI are to tackle several aspects of ARI and other emerging diseases through the implementation of four work packages:

• Strengthening of surveillance through molecular epidemiology and clinical microbiology;

• Development of diagnostic tools and surveillance in adults and children;

• Mechanistic base of pathophysiology and therapy development (small chemicals and vaccine);

• Development of teaching and training programs.

Each work package is comprised of different activities that are being developed in coordination by the participating centers. RESPARI will promote an annual scientific meeting to discuss the progress of the project.